iBio, Inc. (IBIO): Price and Financial Metrics
IBIO Price/Volume Stats
| Current price | $0.93 | 52-week high | $6.89 |
| Prev. close | $0.99 | 52-week low | $0.64 |
| Day low | $0.88 | Volume | 460,300 |
| Day high | $1.00 | Avg. volume | 866,856 |
| 50-day MA | $1.41 | Dividend yield | N/A |
| 200-day MA | $2.55 | Market Cap | 15.30M |
IBIO Stock Price Chart Interactive Chart >
iBio, Inc. (IBIO) Company Bio
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.
IBIO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IBIO Price Returns
| 1-mo | 9.51% |
| 3-mo | -83.39% |
| 6-mo | -66.43% |
| 1-year | -61.89% |
| 3-year | -99.29% |
| 5-year | -99.88% |
| YTD | -62.04% |
| 2024 | 78.83% |
| 2023 | -84.59% |
| 2022 | -96.76% |
| 2021 | -47.71% |
| 2020 | 321.69% |